Antibiotics in Children with Pneumonia: a Review
DOI:
https://doi.org/10.23917/pharmacon.v22i1.8491Keywords:
Pneumonia, Antibiotics, Intensive Care, Pediatric, Antibiotic ResistanceAbstract
Pneumonia is one of the most common infections in children; at the same time, it's also a case that consumes lots of days in hospitals with antibiotics. Essentially, antibiotics are medicines that specifically combat infection produced by bacteria, turning out to be some of the important discoveries in the entire history of medicine. This review aims to analyze the types of sensitive and resistant antibiotics in the management of pneumonia in children. Antibiotic resistance is one of the most dangerous health hazards facing the global community, which has grave consequences economically. The literature search in this study is adopted from both Google Scholar and PubMed. While on Pubmed, the keyword used includes "pneumonia", "antibiotics", "children", "PICU"; on Google Scholar, the word used is antibiotics, pneumonia, pediatric, and intensive care joined by using "AND" or "OR". The inclusion criteria in this literature search include published literature within less than 10 years, between 2014 and 2024; antibiotic articles on use scheme in the PICU; literatur of pneumonia in pediatric; and study review about bacterial type examinations. Thus, other articles were excluded that did not represent any empirical data regarding the study of antibiotics, or those that focused only on one kind of antibiotic sine the contextualization of its usage design. From the outcome of the review, the following bacteria types have been identified to be present in pneumonia patients: M. pneumoniae, Acinetobacter baumannii, Staphylococcus, Pseudomonas, and K. pneumoniae. Tetracycline and fluoroquinolone groups are effective choices of antibiotic classes. Mycoplasma pneumoniae, a common bacteria in pneumonia patients with CAP, is resistant to macrolides, leading to the recommendation of combination therapy or tetracycline antibiotics. Meropenem, widely used in VAP patients, is now limited and recommended for other types.
Downloads
References
Akashi, Y., Hayashi, D., Suzuki, H., Shiigai, M., Kanemoto, K., Notake, S., Ishiodori, T., Ishikawa, H., & Imai, H. (2018). Clinical features and seasonal variations in the prevalence of macrolide-resistant Mycoplasma pneumoniae. Journal of general and family medicine, 19(6), 191–197. https://doi.org/10.1002/jgf2.201
Aygun, F., Aygun, F. D., Varol, F., Durak, C., Cokugraş, H., Camcioglu, Y., & Cam, H. (2019). Can Nebulised Colistin Therapy Improve Outcomes in Critically Ill Children with Multi-Drug Resistant Gram-Negative Bacterial Pneumonia?. Antibiotics (Basel, Switzerland), 8(2), 40. https://doi.org/10.3390/antibiotics8020040
Baran, A., Kwiatkowska, A., & Potocki, L. (2023). Antibiotics and Bacterial Resistance-A Short Story of an Endless Arms Race. International journal of molecular sciences, 24(6), 5777. https://doi.org/10.3390/ijms24065777
Bartlett, A., Padfield, D., Lear, L., Bendall, R., & Vos, M. (2022). A comprehensive list of bacterial pathogens infecting humans. Microbiology (Reading, England), 168(12), 10.1099/mic.0.001269. https://doi.org/10.1099/mic.0.001269
Bhatti, J. M., Raza, S. A., Alam, A. F., Khan, Y. N., Mala, A., Batool, I., & Sameeullah, F. (2023). Antibiotic choices among healthcare professionals for enterococcal bacteremia with patterns of resistance and risk factors of mortality, in settings of poor antibiotic stewardship program - a five-year retrospective cohort study. BMC infectious diseases, 23(1), 514. https://doi.org/10.1186/s12879-023-08498-0
Cook, Michael A., and Gerard D. Wright. (2022). “The Past, Present, and Future of Antibiotics.” Science Translational Medicine 14(657):eabo7793. doi: 10.1126/scitranslmed.abo7793
Ergul, A. B., Cetin, S., Altintop, Y. A., Bozdemir, S. E., Ozcan, A., Altug, U., Samsa, H., & Torun, Y. A. (2017). Evaluation of Microorganisms Causing Ventilator-Associated Pneumonia in a Pediatric Intensive Care Unit. The Eurasian journal of medicine, 49(2), 87–91. https://doi.org/10.5152/eurasianjmed.2017.16262
Fan, C., Yang, M., Mao, Y., Fang, B., He, Y., Li, R., & Qian, S. (2024). Effect of Antimicrobial Stewardship 2018 on severe pneumonia with bacterial infection in paediatric intensive care units. Journal of global antimicrobial resistance, 36, 444–452. https://doi.org/10.1016/j.jgar.2023.10.017
Fan, P., Fu, P., Liu, J., Wang, C., Zhang, X., Wang, Y., Zhang, Y., Zhu, T., Zhang, C., Lu, G., Yan, G., China Paediatric Intensive Care Unit Pathogen Surveillance Network (CHIPS) Study Group, & Members and affiliations of China Paediatric Intensive care Unit Pathogen Surveillance Network (CHIPS) (2024). Monitoring of Klebsiella pneumoniae Infection and Drug Resistance in 17 Pediatric Intensive Care Units in China from 2016 to 2022. Infection and drug resistance, 17, 4125–4136. https://doi.org/10.2147/IDR.S475720
Fu, B., Yin, D., Sun, C., Shen, Y., Liu, D., Bai, R., Zhang, R., Shen, J., Hu, F., & Wang, Y. (2022). Clonal and Horizontal Transmission of blaNDM among Klebsiella pneumoniae in Children's Intensive Care Units. Microbiology spectrum, 10(4), e0157421. https://doi.org/10.1128/spectrum.01574-21
García Romero, R., Fresán-Ruiz, E., Guitart, C., Bobillo-Perez, S., & Jordan, I. (2024). The Use of Ceftazidime-Avibactam in a Pediatric Intensive Care Unit-An Observational Prospective Study. Antibiotics (Basel, Switzerland), 13(11), 1037. https://doi.org/10.3390/antibiotics13111037
Hon, K. L., Leung, A. S., Cheung, K. L., Fu, A. C., Chu, W. C., Ip, M., & Chan, P. K. (2015). Typical or atypical pneumonia and severe acute respiratory symptoms in PICU. The clinical respiratory journal, 9(3), 366–371. https://doi.org/10.1111/crj.12149
Iyer, R. N., Jangam, R. R., Jacinth, A., Venkatalakshmi, A., & Nahdi, F. B. (2017). Prevalence and trends in the antimicrobial susceptibility pattern of Salmonella enterica serovars Typhi and Paratyphi A among children in a pediatric tertiary care hospital in South India over a period of ten years: a retrospective study. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 36(12), 2399–2404. https://doi.org/10.1007/s10096-017-3073-x
Khokhlova, O. E., Hung, W. C., Wan, T. W., Iwao, Y., Takano, T., Higuchi, W., Yachenko, S. V., Teplyakova, O. V., Kamshilova, V. V., Kotlovsky, Y. V., Nishiyama, A., Reva, I. V., Sidorenko, S. V., Peryanova, O. V., Reva, G. V., Teng, L. J., Salmina, A. B., & Yamamoto, T. (2015). Healthcare- and Community-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) and Fatal Pneumonia with Pediatric Deaths in Krasnoyarsk, Siberian Russia: Unique MRSA's Multiple Virulence Factors, Genome, and Stepwise Evolution. PloS one, 10(6), e0128017. https://doi.org/10.1371/journal.pone.0128017
Kim, Y. J., Shin, K. S., Lee, K. H., Kim, Y. R., & Choi, J. H. (2017). Clinical Characteristics of Macrolide-Resistant Mycoplasma pneumoniae from Children in Jeju. Journal of Korean medical science, 32(10), 1642–1646. https://doi.org/10.3346/jkms.2017.32.10.1642
Lee, E., Cho, H. J., Hong, S. J., Lee, J., Sung, H., & Yu, J. (2017). Prevalence and clinical manifestations of macrolide resistant Mycoplasma pneumoniae pneumonia in Korean children. Korean journal of pediatrics, 60(5), 151–157. https://doi.org/10.3345/kjp.2017.60.5.151
Lim W. S. (2022). Pneumonia—Overview. Encyclopedia of Respiratory Medicine, 185–197. https://doi.org/10.1016/B978-0-12-801238-3.11636-8
Mathot, F., Duke, T., Daley, A. J., & Butcher, T. (2015). Bacteremia and pneumonia in a tertiary PICU: an 11-year study. Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 16(2), 104–113. https://doi.org/10.1097/PCC.0000000000000300
Pulingam, T., Parumasivam, T., Gazzali, A. M., Sulaiman, A. M., Chee, J. Y., Lakshmanan, M., Chin, C. F., & Sudesh, K. (2022). Antimicrobial resistance: Prevalence, economic burden, mechanisms of resistance and strategies to overcome. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 170, 106103. https://doi.org/10.1016/j.ejps.2021.106103
Saeedi, F. A., Hegazi, M. A., Alsaedi, H., Alganmi, A. H., Mokhtar, J. A., Metwalli, E. M., Hamadallah, H., Siam, G. S., Alaqla, A., Alsharabi, A., & Alotaibi, S. A. (2024). Multidrug-Resistant Bacterial Infections in Pediatric Patients Hospitalized at King Abdulaziz University Hospital, Jeddah, Western Saudi Arabia. Children (Basel, Switzerland), 11(4), 444. https://doi.org/10.3390/children11040444
Tramper-Stranders G. A. (2018). Childhood community-acquired pneumonia: A review of etiology- and antimicrobial treatment studies. Paediatric respiratory reviews, 26, 41–48. https://doi.org/10.1016/j.prrv.2017.06.013
Tsai, T. A., Tsai, C. K., Kuo, K. C., & Yu, H. R. (2021). Rational stepwise approach for Mycoplasma pneumoniae pneumonia in children. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 54(4), 557–565. https://doi.org/10.1016/j.jmii.2020.10.002
Uddin, T. M., Chakraborty, A. J., Khusro, A., Zidan, B. R. M., Mitra, S., Emran, T. B., Dhama, K., Ripon, M. K. H., Gajdács, M., Sahibzada, M. U. K., Hossain, M. J., & Koirala, N. (2021). Antibiotic resistance in microbes: History, mechanisms, therapeutic strategies and future prospects. Journal of infection and public health, 14(12), 1750–1766. https://doi.org/10.1016/j.jiph.2021.10.020
Walter, J., Haller, S., Quinten, C., Kärki, T., Zacher, B., Eckmanns, T., Abu Sin, M., Plachouras, D., Kinross, P., Suetens, C., & ECDC PPS study group (2018). Healthcare-associated pneumonia in acute care hospitals in European Union/European Economic Area countries: an analysis of data from a point prevalence survey, 2011 to 2012. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 23(32), 1700843. https://doi.org/10.2807/1560-7917.ES.2018.23.32.1700843
Wang, Y. S., Zhou, Y. L., Bai, G. N., Li, S. X., Xu, D., Chen, L. N., Chen, X., Dong, X. Y., Fu, H. M., Fu, Z., Hao, C. L., Hong, J. G., Liu, E. M., Liu, H. M., Lu, X. X., Luo, Z. X., Tang, L. F., Tian, M., Yin, Y., Zhang, X. B., … Chen, Z. M. (2024). Expert consensus on the diagnosis and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children. World journal of pediatrics : WJP, 20(9), 901–914. https://doi.org/10.1007/s12519-024-00831-0
Wattal, C., & Goel, N. (2020). Pediatric Blood Cultures and Antibiotic Resistance: An Overview. Indian journal of pediatrics, 87(2), 125–131. https://doi.org/10.1007/s12098-019-03123-y
Williams, D. J., Martin, J. M., Nian, H., Weitkamp, A. O., Slagle, J., Turer, R. W., Suresh, S., Johnson, J., Stassun, J., Just, S. L., Reale, C., Beebe, R., Arnold, D. H., Antoon, J. W., Rixe, N. S., Sartori, L. F., Freundlich, R. E., Ampofo, K., Pavia, A. T., Smith, J. C., … Grijalva, C. G. (2023). Antibiotic clinical decision support for pneumonia in the ED: A randomized trial. Journal of hospital medicine, 18(6), 491–501. https://doi.org/10.1002/jhm.13101
Wong, J. J. M., Abbas, Q., Wang, J. Q. Y., Xu, W., Dang, H., Phan, P. H., Guo, L., Lee, P. C., Zhu, X., Angurana, S. K., Pukdeetraipop, M., Efar, P., Yuliarto, S., Choi, I., Fan, L., Hui, A. W. F., Gan, C. S., Liu, C., Samransamruajkit, R., Cho, H. J., … Pediatric Acute and Critical Care Asian Network (PACCMAN) (2024). Severe Pneumonia in PICU Admissions: The Pediatric Acute and Critical Care Medicine Asian Network (PACCMAN) Observational Cohort Study, 2020-2022. Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 25(11), 1035–1044. https://doi.org/10.1097/PCC.0000000000003598
Xu, L., & Fang, C. (2023). Case Report: Omadacycline in the treatment of macrolide-unresponsive Mycoplasma pneumoniae pneumonia in an adolescent patient. Frontiers in cellular and infection microbiology, 13, 1244398. https://doi.org/10.3389/fcimb.2023.1244398
Zhang, T., Xu, X., Xu, C. F., Bilya, S. R., & Xu, W. (2021). Mechanical ventilation-associated pneumonia caused by Acinetobacter baumannii in Northeast China region: analysis of genotype and drug resistance of bacteria and patients' clinical features over 7 years. Antimicrobial resistance and infection control, 10(1), 135. https://doi.org/10.1186/s13756-021-01005-7
Zhao, W., Pan, F., Wang, B., Wang, C., Sun, Y., Zhang, T., Shi, Y., & Zhang, H. (2019). Epidemiology Characteristics of Streptococcus pneumoniae From Children With Pneumonia in Shanghai: A Retrospective Study. Frontiers in cellular and infection microbiology, 9, 258. https://doi.org/10.3389/fcimb.2019.00258
Zhou, Y., Shan, Y., Cui, Y., Shi, J., Wang, F., Miao, H., Wang, C., & Zhang, Y. (2021). Characteristics and Outcome of Severe Mycoplasma pneumoniae Pneumonia Admitted to PICU in Shanghai: A Retrospective Cohort Study. Critical care explorations, 3(3), e0366. https://doi.org/10.1097/CCE.0000000000000366
